← Open Payments lookup

KOLADE AJAYI: Open Payments

NPI 1427521186 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$500 in 29 payments from 8 companies in 2025. Trend: 2023 $120 · 2024 $258 · 2025 $500

Food & beverage: $500
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.17$234
E.R. Squibb & Sons, L.L.C.3$66
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$52
ABBVIE INC.2$37
Teva Pharmaceuticals USA, Inc.2$36
Neurocrine BioSciences, Inc.1$30
Janssen Pharmaceuticals, Inc1$28
Lundbeck LLC1$18

Products named: REXULTI, COBENFY, CAPLYTA, VRAYLAR, INGREZZA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, AUSTEDO XR.

Industry payments across TX — which companies pay providers there.